Bibliographic citations
Centeno, V., Chang, M. (2019). Prevalencia y factores asociados a la obesidad metabólicamente normal en pacientes adultos obesos en dos establecimientos de salud durante el 2014 al 2016 en Lima, Perú [Tesis, Universidad Peruana de Ciencias Aplicadas (UPC)]. http://hdl.handle.net/10757/628125
Centeno, V., Chang, M. Prevalencia y factores asociados a la obesidad metabólicamente normal en pacientes adultos obesos en dos establecimientos de salud durante el 2014 al 2016 en Lima, Perú [Tesis]. PE: Universidad Peruana de Ciencias Aplicadas (UPC); 2019. http://hdl.handle.net/10757/628125
@misc{renati/369593,
title = "Prevalencia y factores asociados a la obesidad metabólicamente normal en pacientes adultos obesos en dos establecimientos de salud durante el 2014 al 2016 en Lima, Perú",
author = "Chang Pinto, Martin Alberto",
publisher = "Universidad Peruana de Ciencias Aplicadas (UPC)",
year = "2019"
}
Introduction. Globally, the 27,5% of adult population is overweight or obese. Becoming an obese person increases the risk of developing Metabolic Syndrome (MS); however, there are obese people who do not have MS and are known as Metabolically Normal Obese (MNO). In this study, we consider to define MNO patients as obese patients (IMC≥30 kg/m2) without MS. On the other hand, MS is defined as the presence of three or more of the following parameters outside of their normal limits: abdominal circumference, triglyceride levels, HDL-c levels, blood pressure and glucose levels. Objectives. The aim of this study is to know the prevalence and to identify some factors associated to being MNO. Methods. A cross sectional, analytical observational study was conducted, collecting data retrospectively from medical records at the “Clinica Internacional” –Lima (CI) and at the “Hospital Nacional Dos de Mayo” (HNDM), with a sample of 675 participants. Results. The prevalence of MNO in both health facilities (HFs) was 35,11%. The participants in both HFs were mostly women (65,19%), with an average of 51 years. Regarding the diet, it was found that 81,66% of the patients who go to the HNDM, and 89,61% of those who go to the CI, do not have a balanced diet (p=0.004). Furthermore, 53,88% of obese people with MS and 38,82% of MNOs have high cholesterol values (>200mg/dL) (p<0.001). In the adjusted analysis, we found that for extra year of the patient’s life, the probability of being MNO decreases by 2% (PR=0.98; p<0.000; 95%CI: 0.97-0.99). Conclusion. In our population, we found a MNO prevalence of 35,11%, which is higher than previously reported in the country. This difference in the prevalence of MNO may be due to different authors defining MNO in different ways. Moreover, we found out that the most important factor influencing the presence of MNO is age.
This item is licensed under a Creative Commons License